Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanes.
Saijo N, Nishio K, Ohta S, Arioka H, Funayama Y, Fukuoka K, Kurokawa H, Nomoto T, Ishida T, Yamamoto N, Tamura T, Shinkai T, Eguchi K, Ohe Y, Kunito H, Ohtsu T, Sasaki Y.
Saijo N, et al. Among authors: ohtsu t.
Cancer Chemother Pharmacol. 1996;38 Suppl:S11-5. doi: 10.1007/s002800051030.
Cancer Chemother Pharmacol. 1996.
PMID: 8765409
Review.
No abstract available.